Présentation
LabEx IBEID
Integrative Biology for Emerging Infectious Diseases
Twelfth Annual Meeting – June 12 2023
09h15-9h30 Philippe Bastin, scientific LabEx co-coordinator
Welcome and introduction
"1st Session" Carla Saleh, Chair
09h30 Guest speaker: Raina K. Plowright (Cornell University, USA)
Looking left: ecological approaches to preventing pandemics
10h10 Marie Bourdon (4th call PhD, Xavier Montagutelli)
Genetic and functional dissection of Zika virus susceptibility in the mouse
10h30 Robert Smith (5th call Post-doc, Simonetta Gribaldo)
Can we repeat the diderm-to-monoderm transition in the laboratory?
10h50: Coffee break
"2nd Session" Mélanie Hamon, Chair
11h20 Sebastian Castro Ramirez (G5 Epigénomique fongique, Eugene Gladyshev)
Conserved chromatin remodeler ATRX/SAD-6 controls transcriptional and post-transcriptional gene silencing in Neurospora crassa
11h40 Julian Buchrieser (5th call Post-doc, Olivier Schwartz)
Coronavirus fusion and entry
12h00 Jorge Andre SOUSA (2nd call S2I, Eduardo Rocha)
“parasites all the way down”: Exploring the abundance and diversity of phage satellites in bacterial genomes
12h20 Eva Krupa (5th call Post-doc, Sarah Bonnet)
Microbiological monitoring, new horizons for tick-borne diseases: tick presence according to the ecosystem in urban and peri-urban environments in the Ile de France region
12h40: Buffet lunch
"3rd Session" Jean-Claude Manuguerra, Chair
14h00 Carla Saleh
Presentation of the Institut Pasteur – UCSF QBI Center of Excellence in Emerging Infectious Diseases
14h15 Yann Aquino (2nd call GIL, L Abel & L Quintana-Murci)
Single-cell transcriptional responses to SARS-CoV-2 across human populations
14h35 Richard Girard (6th call Post-doc, Rogerio Amino)
New insights on Plasmodium oocyst development
14h55: Coffee break
"4th Session" Lucy Glover, Chair
15h10 Marine Viglietta (1st call GIL, AB Failloux & C Saleh)
Importance of arboviruses co-infections in yellow fever virus exclusion in Asia
15h30 Jakub Czarnecki (6th call Post-doc, Didier Mazel)
Development of a toxin-based therapy that selectively combat multi-resistant bacterial pathogens in the human gut
15h50 Carla Saleh, scientific LabEx co-coordinator
Conclusions